Valuation (14%) |
Company | Industry |
---|---|---|
P/E Ratio (TTM) | -0.01 | -10.90 |
PEG Ratio (TTM) | N/A | -0.60 |
P/S Ratio (TTM) | 0.57 | 12.04 |
P/B Ratio (TTM) | 4.06 | 3.49 |
P/FCF Ratio (TTM) | -1.89 | 20.86 |
Price to 5YR AVG Earnings Ratio | -0.01 | 16.52 |
Price to 5YR AVG FCF Ratio | -23.83 | -22.84 |
Profitability (25%) |
Company | Industry |
---|---|---|
ROA (TTM) | -14,993.75% | -73.42% |
ROE (TTM) | -59,727.08% | -303.62% |
Net Profit Margin (TTM) | -5,338.08% | -36.60% |
ROIC 5YR AVG | 399.34% | -10.68% |
Growth (25%) |
4QTR AVG | 3YR AVG | 5YR AVG |
---|---|---|---|
EPS | -17,716.62% | 42.56% | -41.05% |
Revenue | 23,163.64% | -8.66% | -31.97% |
Net Income | -19,412.67% | -38.92% | -178,876.84% |
Cash Flow | 16.27% | -57.60% | -77.96% |
Health (33%) |
Company | Industry |
---|---|---|
Current Ratio (TTM) | 3.54 | 3.07 |
Quick Ratio (TTM) | 3.54 | 2.81 |
D/E Ratio (TTM) | 438.19 | 2.94 |
Interest Coverage (TTM) | -3,501.70 | 127.36 |
Piotroski F-Score | 2 | 6 |
Altman Z-Score | N/A | 12.41 |
LTL to 5YR AVG FCF | -2.46 | -3.09 |
Shares Outstanding Growth 5YR AVG | 116.63% | 16.60% |